01
Low NADAC$1.03
→
Avg plan cost$1.03
Part D spend $76946
1× spread, current vs floor
1 molecule in this class, $76946 combined CY2024 Part D spend across 9K claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.
Every drug in the Benzodiazepine Antagonist class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.